BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 12916055)

  • 21. Synthesis, X-ray crystallographic analysis, and antitumor activity of N-(benzothiazole-2-yl)-1-(fluorophenyl)-O,O-dialkyl-alpha-aminophosphonates.
    Jin L; Song B; Zhang G; Xu R; Zhang S; Gao X; Hu D; Yang S
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1537-43. PubMed ID: 16406612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
    Gangjee A; Adair OO; Queener SF
    J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
    Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of 2,8-disubstituted imidazo[1,5-a]pyrimidines with potent antitumor activity.
    Matsumoto H; Ikeda K; Nagata N; Takayanagi H; Mizuno Y; Tanaka M; Sasaki T
    J Med Chem; 1999 May; 42(9):1661-6. PubMed ID: 10229634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, antiproliferative and apoptosis-inducing activity of thiazolo[5,4-d]pyrimidines.
    Singh B; Guru SK; Kour S; Jain SK; Sharma R; Sharma PR; Singh SK; Bhushan S; Bharate SB; Vishwakarma RA
    Eur J Med Chem; 2013; 70():864-74. PubMed ID: 24262379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
    Al-Saadi MS; Rostom SA; Faidallah HM
    Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel pyrazoles and pyrazolo[3,4-d]pyrimidines incorporating a benzenesulfonamide moiety.
    Ashour HM; Wahab AE
    Arch Pharm (Weinheim); 2009 Apr; 342(4):238-52. PubMed ID: 19340837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
    Rostom SA; Ashour HM; Abd El Razik HA
    Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS; Faidallah HM; Rostom SA
    Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines.
    Gangjee A; Adair O; Queener SF
    J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrimidines. Part II: Synthesis of novel pyrimidines, 1,2,4-triazolo[4,3-a]pyrimidin-7-ones and pyrimidino[2,1-c][1,2,4]triazin-8-ones for their antimicrobial and anticancer activities.
    Habib NS; Soliman R; Ismail K; Hassan AM; Sarg MT
    Boll Chim Farm; 2003 Nov; 142(9):396-405. PubMed ID: 14971308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological evaluation of certain new thiazolopyrimidines.
    el-Bendary ER; el-Sherbeny MA; Badria FA
    Boll Chim Farm; 1998 Apr; 137(4):115-9. PubMed ID: 9618969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syntheses of novel heterocycles as anticancer agents.
    Chauhan PM; Martins CJ; Horwell DC
    Bioorg Med Chem; 2005 May; 13(10):3513-8. PubMed ID: 15848764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; El-Hazek RM
    Eur J Med Chem; 2011 Oct; 46(10):5120-6. PubMed ID: 21890248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anticancer activity of novel 3,4-diarylthiazol-2(3H)-ones (imines).
    Liu ZY; Wang YM; Li ZR; Jiang JD; Boykin DW
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5661-4. PubMed ID: 19713108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and anticancer activity of new thiazolo[3,2-a]pyrimidines: DNA binding and molecular modeling study.
    Hassan GS; El-Messery SM; Abbas A
    Bioorg Chem; 2017 Oct; 74():41-52. PubMed ID: 28750204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Biginelli dihydropyrimidines with potential anticancer activity: a parallel synthesis and CoMSIA study.
    Prashantha Kumar BR; Sankar G; Nasir Baig RB; Chandrashekaran S
    Eur J Med Chem; 2009 Oct; 44(10):4192-8. PubMed ID: 19525040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and cytotoxic activity of new isothiazolo[5,4-d]pyrimidine derivatives.
    Lipnicka U; Regiec A; Machon Z
    Pharmazie; 1994 Sep; 49(9):642-6. PubMed ID: 7972309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of some novel fused pyrazolopyrimidines as potential anticancer and antimicrobial agents.
    Abd El Razik HA; Wahab AE
    Arch Pharm (Weinheim); 2011 Mar; 344(3):184-96. PubMed ID: 21384418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.